Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea. - Wikidata - awgldk - TriplyDB

Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.

Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.

http://www.wikidata.org/entity/Q37600575

about

Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.

http://www.wikidata.org/entity/Q37600575

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@en

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@nl

type

label

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@en

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@nl

prefLabel

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@en

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@nl

P1433

Q37600575-D8A808BD-3962-40B0-9F22-7098DF46BE00

P1476

Q37600575-DCC4A95D-7629-4C60-9CBF-E185D7E3512A

P2093

Q37600575-0989E98A-31E5-4F60-91EB-02CD7AB4699B

Q37600575-7E329765-DEC1-428F-8C12-83671AF9C609

Q37600575-7EBE86FD-726F-4EB6-9504-23747392C9FB

Q37600575-83EC4A6A-340A-43B2-B56D-F9086B4ED648

Q37600575-90842185-5330-43AC-9050-AB63069BD801

Q37600575-FBD90B61-413E-4F54-9D46-10A12656E72F

P2860

Q37600575-0E690BC8-4541-49C7-9F9C-78DA60B990B5

Q37600575-1315A568-9F3D-443D-99A4-A0B2E26A3B17

Q37600575-17B0F1F7-9AF7-4E0A-8511-DFB0ED5E017A

Q37600575-1BB69F81-187F-470F-8C51-6A5F2106252B

Q37600575-1F3EA406-4DF9-4FBA-8E69-7BDE052DB5B0

Q37600575-2EB9643D-08A7-4655-BBD0-B6D4F60DFAAD

Q37600575-354883F3-0DE5-4352-92CB-0A59EE3BD1A7

Q37600575-374651B9-63E4-412E-88C9-151F0B470E2A

Q37600575-39F7EE56-B876-4052-BF93-8B4A887F70C6

Q37600575-40201507-B98F-4076-8D99-3F08C2C048E3

P304

Q37600575-0A318144-A967-47E7-AFB5-AFD25B7CFDF0

P31

Q37600575-B1034D46-E0FE-4E7E-BCD2-44747F06748E

P356

Q37600575-23F53350-29CA-4AB9-BB97-23054CE86CE9

P407

Q37600575-0AD86658-0259-415C-B892-76415B7CAE18

P433

Q37600575-D8A986D8-1F18-45C5-82ED-DC5DBC80DF13

P478

Q37600575-3E6CB2DA-F73D-42D4-95FD-90E84F2B9C01

P577

Q37600575-2959711D-C827-4E47-B2F1-B9C3C9A3DB9F

P698

Q37600575-32B94B40-635A-4100-B7D3-E76C74823F0A

P932

Q37600575-98FBC04E-E4DA-477E-8C88-E126413A1311

P356

JOURNAL.PONE.0170362

P1433

P1476

Treatment Efficacy and Safety ...... al Life Cohort Study in Korea.

@en

P2093

Hyo Jun Ahn

http://www.w3.org/2001/XMLSchema#string

Jeong Won Jang

http://www.w3.org/2001/XMLSchema#string

Jong Young Choi

http://www.w3.org/2001/XMLSchema#string

Myeong Jun Song

http://www.w3.org/2001/XMLSchema#string

Seung Kew Yoon

http://www.w3.org/2001/XMLSchema#string

Si Hyun Bae

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains

Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.

Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

P304

e0170362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0170362

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28114428

http://www.w3.org/2001/XMLSchema#string

P932

5256915

http://www.w3.org/2001/XMLSchema#string